Biocon share price today, January 31: The share price of Biocon has fallen more than 5% in the last five trading days. (Image: Freepik) The share price of Biocon rose almost 4% to an intra-day ...

HYDERABAD, Jan 30 (Reuters) - Indian biopharma company Biocon (BION.NS), opens new tab reported third-quarter revenue on Thursday that fell about 3% when compared with the year-earlier period ...

HYDERABAD -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for a double-digit share in its core U.S. market for its new launches ...

The pro-localisation policy in the US will not impact Biocon Biologics’ revenue, noted Shreehas Tambe, CEO of Biocon Biologics. The US, which contributes 40 per cent of the company’s revenue ...

HYDERABAD, Jan 31 (Reuters) - Indian biopharmaceutical firm Biocon (BION.NS), opens new tab is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core ...

HYDERABAD (Reuters) -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a ...

Kiran shares her visionary journey, insights, and innovations in advancing biotechnology through the development of Biocon.

Kiran shares her journey, vision, and the innovations that have driven Biocon's growth and impact in the biotechnology sector.

Q3 Earnings, Results Today: Today, majors like Tata Consumer, L&T, Max Healthcare, Dabur, Biocon, Adani Enterprises, and others are releasing their Q3 results. (Image: Freepik) India Inc is ...

Biocon share price: Biocon reported a 96% year-on-year (YoY) decline in net profit, which fell to Rs 25 crore in Q3FY25. In comparison, the company had posted a net profit of Rs 660 crore in Q3FY24, ...

Biocon's board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected to complete by February 1, 2025. Despite a ...

Biocon share price gained 3.82 per cent at Rs 370.80 a piece on the BSE in Friday’s intraday trade after the company’s earnings for the third quarter of financial year 2024-25 (Q3FY25). The pharma ...